Efficacy and Treatment Satisfaction of Different Systemic Therapies in Children and Adolescents with Moderate-to-Severe Atopic Dermatitis: A Real-World Study

For the treatment of moderate-to-severe atopic dermatitis in children and adolescents, the monoclonal antibody dupilumab and the selective JAK-1 inhibitor upadacitinib are two modern systemic therapies approved for long-term treatment. Both drugs have demonstrated high efficacy in randomized control...

Descripción completa

Detalles Bibliográficos
Autores principales: Kiefer, Sebastian, König, Anke, Gerger, Viviane, Rummenigge, Christine, Müller, Anne Christine, Jung, Thomas, Frank, Alexandra, Tassopoulos, Georgios, Laurent, Emilie, Kaufmann, Roland, Pinter, Andreas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9917393/
https://www.ncbi.nlm.nih.gov/pubmed/36769820
http://dx.doi.org/10.3390/jcm12031175

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9917393/
https://www.ncbi.nlm.nih.gov/pubmed/36769820
http://dx.doi.org/10.3390/jcm12031175

Ejemplares similares